Fc γ receptor compositional heterogeneity: Considerations for immunotherapy development
Open Access
- 1 January 2021
- journal article
- review article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 296, 100057
- https://doi.org/10.1074/jbc.rev120.013168
Abstract
No abstract availableKeywords
Funding Information
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- National Institute of General Medical Sciences (R01 GM115489, R21 AI142122)
- National Institute of Allergy and Infectious Diseases
This publication has 72 references indexed in Scilit:
- Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activityJCI Insight, 2013
- ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophilsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2013
- Autologous stem cell transplant recipients tolerate haploidentical related‐donor natural killer cell–enriched infusionsTransfusion, 2012
- Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicityBlood, 2010
- Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safetyLeukemia, 2010
- Efficient Glycosynthase Mutant Derived from Mucor hiemalis Endo-β-N-acetylglucosaminidase Capable of Transferring Oligosaccharide from Both Sugar Oxazoline and Natural N-GlycanPublished by Elsevier BV ,2010
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast CancerJournal of Clinical Oncology, 2008
- Isolation of anti-CD22 Fv with high affinity by Fv display on human cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular LymphomaJournal of Clinical Oncology, 2003
- Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular ToxicityJournal of Biological Chemistry, 2002